LINCOLN Pharmaceuticals | LINCOPH | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net Income |
| 368 | 462 | 622 | 672 | 837 |
Cash flow Operating Act... |
| 206 | 231 | 528 | 754 | 693 |
Investments in PPE |
| -176 | -99 | -149 | -77 | -88 |
Cash flow Investing Act... |
| -230 | -83 | -182 | -309 | -642 |
Dividend Paid |
| 20 | 29 | 36 | 72 | 0 |
Cash flow Financing Act... |
| 19 | -114 | -358 | -378 | -57 |
Cash at beginning of period |
| 34 | 31 | 66 | 55 | 121 |
Cash at end of period |
| 30 | 66 | 55 | 122 | 114 |
Free Cash Flow |
| 30 | 132 | 379 | 677 | 605 |